YM155 exerts potent cytotoxic activity against quiescent (G0/G1) multiple myeloma and bortezomib resistant cells via inhibition of survivin and Mcl-1.
| Image |  |
|---|---|
| Description | scientific article published on 4 December 2017 |
| Author/s |
author: Hideki Yagi |
| Publication date | December 4, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |